<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Kr√ºppel-like factor 4 (KLF4), a zinc finger-containing transcriptional factor, is a pivotal regulator of cellular fate </plain></SENT>
<SENT sid="1" pm="."><plain>KLF4 has attracted considerable attention for its opposing effect in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> as <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor (e.g. <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>) or oncoprotein (e.g. <z:hpo ids='HP_0003002'>breast cancer</z:hpo>), depending on tissue context, with the underlying mechanism remaining largely unknown </plain></SENT>
<SENT sid="2" pm="."><plain>Here we report that KLF4 mediates <z:chebi fb="0" ids="50114">estrogen</z:chebi> signaling in <z:hpo ids='HP_0003002'>breast cancer</z:hpo> formation </plain></SENT>
<SENT sid="3" pm="."><plain>Accumulation of KLF4 by inhibiting its turnover triggers <z:chebi fb="0" ids="50114">estrogen</z:chebi>-induced transactivation </plain></SENT>
<SENT sid="4" pm="."><plain>We identified Von Hippel-Lindau, pVHL, as the protein that governs KLF4 turnover in <z:hpo ids='HP_0003002'>breast cancer</z:hpo> cells and demonstrated that <z:chebi fb="0" ids="50114">estrogen</z:chebi>-induced down-regulation of pVHL facilitates accumulation of KLF4 </plain></SENT>
<SENT sid="5" pm="."><plain>We provide mechanistic insights into KLF4 steady-state degradation as well as its elevation in the presence of <z:chebi fb="0" ids="50114">estrogen</z:chebi> and show that elevated levels of pVHL or <z:mpath ids='MPATH_63'>depletion</z:mpath> of KLF4 attenuates the <z:chebi fb="0" ids="50114">estrogen</z:chebi>-induced transactivation and cell growth </plain></SENT>
<SENT sid="6" pm="."><plain>Finally, immunohistochemical staining revealed reduced concentration of pVHL and accumulation of KLF4 in <z:hpo ids='HP_0003002'>breast cancer</z:hpo> tissues </plain></SENT>
<SENT sid="7" pm="."><plain>We thus propose that suppression of pVHL in response to <z:chebi fb="0" ids="50114">estrogen</z:chebi> signaling results in elevation of KLF4, which mediates <z:chebi fb="0" ids="50114">estrogen</z:chebi>-induced mitogenic effect </plain></SENT>
</text></document>